1. Home
  2. PMM vs LCTX Comparison

PMM vs LCTX Comparison

Compare PMM & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Putnam Managed Municipal Income Trust

PMM

Putnam Managed Municipal Income Trust

HOLD

Current Price

$6.35

Market Cap

269.4M

Sector

Finance

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.23

Market Cap

301.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMM
LCTX
Founded
1989
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
269.4M
301.7M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
PMM
LCTX
Price
$6.35
$1.23
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$6.25
AVG Volume (30 Days)
86.8K
1.0M
Earning Date
01-01-0001
05-14-2026
Dividend Yield
4.68%
N/A
EPS Growth
N/A
N/A
EPS
0.23
N/A
Revenue
N/A
$14,556,000.00
Revenue This Year
N/A
$109.40
Revenue Next Year
N/A
N/A
P/E Ratio
$27.65
N/A
Revenue Growth
N/A
53.24
52 Week Low
$5.77
$0.85
52 Week High
$6.52
$2.09

Technical Indicators

Market Signals
Indicator
PMM
LCTX
Relative Strength Index (RSI) 66.57 41.61
Support Level $6.06 N/A
Resistance Level $6.40 $1.80
Average True Range (ATR) 0.05 0.07
MACD 0.01 0.01
Stochastic Oscillator 100.00 16.75

Price Performance

Historical Comparison
PMM
LCTX

About PMM Putnam Managed Municipal Income Trust

Putnam Managed Municipal Income Trust is a closed-end management investment company. Its investment objective is to seek a high level of current income exempt from federal income tax by investing in a diversified portfolio of tax-exempt municipal securities. The Fund invests in various sectors such as healthcare, retirement community, private higher education, housing-backed, essential service utilities, and state-backed bonds.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: